pTM1_VP30_ZEBOV Citations (2)
Originally described in: The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals.Trunschke M, Conrad D, Enterlein S, Olejnik J, Brauburger K, Muhlberger E Virology. 2013 Jul 5;441(2):135-45. doi: 10.1016/j.virol.2013.03.013. Epub 2013 Apr 11. PubMed Journal
Articles Citing pTM1_VP30_ZEBOV
| Articles |
|---|
A Chimeric Lloviu Virus Minigenome System Reveals that the Bat-Derived Filovirus Replicates More Similarly to Ebolaviruses than Marburgviruses.
Manhart WA, Pacheco JR, Hume AJ, Cressey TN, Deflube LR, Muhlberger E.
Cell Rep. 2018 Sep 4;24(10):2573-2580.e4. doi: 10.1016/j.celrep.2018.08.008.
PubMed
Associated Plasmids |
| Comparison of Zaire and Bundibugyo Ebolavirus Polymerase Complexes and Susceptibility to Antivirals through a Newly Developed Bundibugyo Minigenome System. Levine CB, Mire CE, Geisbert TW. J Virol. 2021 Sep 27;95(20):e0064321. doi: 10.1128/JVI.00643-21. Epub 2021 Aug 11. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.